Prognosis in UC After First Biological

Clinical Outcome of Treatment of Ulcerative Colitis in Adult

NCT06143163 ·Status: NOT_YET_RECRUITING

Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis

NCT00573794 ·Status: COMPLETED ·Phase: PHASE3

Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study

NCT06802887 ·Status: RECRUITING

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

NCT02065622 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Adalimumab for Ulcerative Colitis Patients

NCT00421642 ·Status: COMPLETED ·Phase: PHASE1

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

NCT07242248 ·Status: RECRUITING

Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients

NCT05720221 ·Status: COMPLETED

LFMT vs Placebo in New Biologic Start for Ulcerative Colitis

NCT05327790 ·Status: RECRUITING ·Phase: PHASE2

Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases

NCT03606499 ·Status: COMPLETED

Immune Regulation in Ulcerative Colitis or Crohn s Disease

NCT00001184 ·Status: RECRUITING

The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab

NCT05896943 ·Status: COMPLETED

Faecal Microbiota Transplantation in Ulcerative Colitis

NCT01896635 ·Status: COMPLETED ·Phase: PHASE2

Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

NCT06269185 ·Status: COMPLETED

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)

NCT03006068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis

NCT00385736 ·Status: COMPLETED ·Phase: PHASE3

Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization

NCT03182166 ·Status: COMPLETED ·Phase: PHASE2

Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA

Prediction Model for Response to Biologics and Small Molecular Agent for UC

NCT05186623 ·Status: RECRUITING

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

NCT00207688 ·Status: COMPLETED

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

NCT06095596 ·Status: RECRUITING ·Phase: NA

Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerative Colitis

NCT04550130 ·Status: UNKNOWN ·Phase: NA

Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis

NCT05867329 ·Status: RECRUITING ·Phase: PHASE4

Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis

NCT04818788 ·Status: UNKNOWN

The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative Colitis

NCT05606939 ·Status: UNKNOWN

Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis

NCT02227342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2